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Background & aims: Low-grade inﬂammation is associated with fat mass in overweight. Whether this
association exists in lean persons is unknown.
Aims were to investigate associations between anthropometric measures of fat distribution and fat mass
(% and kg) assessed by bioelectrical impedance analysis (BIA). Furthermore we wanted to investigate the
relationship between fat mass and markers of insulin resistance, inﬂammation, and lipids in healthy
subjects in different BMI categories.
Methods: We compared 47 healthy overweight adults (BMI 26e40 kg/m2) and 40 lean (BMI 17e25 kg/
m2) matched for age and sex. Waist and hip circumferences, waist-to-hip ratio, waist-to-height ratio and
triceps skinfold were used to evaluate fat distribution. BIA was used to estimate fat mass (% and kg).
Markers of insulin resistance, lipids, inﬂammation and adipokines were measured.
Results: Hip circumference was associated (P < 0.01) with BIA-assessed fat mass (%) in both groups (lean:
regression coefﬁcient B ¼ 0.4; overweight: B ¼ 0.5). An increase in hip circumference in all tertiles was
associated with higher plasma levels of leptin, CRP and C-peptide in both groups.
Conclusions: Fat mass may play a role in low-grade inﬂammation also in subjects within the normal range
of BMI. Hip circumference may be a surrogate measure for fat mass in subjects in different BMI cate-
gories, and may be useful for identiﬁcation of people with risk of developing overweight-related chronic
diseases.
 2012 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights
reserved.1. Introduction
The prevalence of overweight and obesity has increased
dramatically worldwide.1 Frequently associated health risks are
insulin resistance, elevated blood pressure and hypercholesterol-
emia, which may lead to type 2 diabetes and cardiovascular
disease.2 The most important determinant of these problems is not
the increased body mass per se, but rather the total amount of fat,
its distribution in the body and metabolic factors that are related toBarcelona, Spain.
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rweight and in lean, heafat tissue mass.3 Fat tissue is an active endocrine organ releasing
adipokines (leptin, adiponectin, resistin) and inﬂammatory factors,
e.g., interleukin (IL)-6.4 These mediators modify carbohydrate- and
lipid-metabolism and contribute to insulin resistance, hyperlipid-
emia and inﬂammatory processes.5 It is well known that inﬂam-
matory markers are associated with fat mass in overweight and
obese subjects,6 but this relation between fat mass and inﬂam-
matory markers in lean subjects is not well documented.7
Several methods are used to measure the amount of fat in
adults. One of the most accurate methods is Dual-energy X-ray
absorptiometry (DXA),7 but measuring fat this way is costly and not
readily available in clinical practice. Bioelectrical impedance anal-
ysis (BIA) is more available and widely used outside hospitals,8 and
an objective, quick and non-invasive method for assessment of fat
and fat free mass.9,10 Validation studies of BIA against DXA showedished by Elsevier Ltd. All rights reserved.
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populations.11 The most common population-level measure is
probably estimation of body mass index (BMI).12 Whether BMI is
a good marker to deﬁne obesity and health status is debated.13
Studies have shown that BMI fails to differentiate between
elevated body fat and increased lean mass, especially in subjects
with a BMI < 30 kg/m2, a frequent cut-off for obesity.12 Other
anthropometric measures, such as waist circumference, hip
circumference, waist-to-hip ratio, waist-to-height ratio and triceps
skinfold, are often used to determine fat distribution.13,14 Like BMI
all these measures are just proxies of fat mass, but may predict
adverse outcomes.14 The INTERHEART Study showed that
increasing waist-to-hip ratio was a predictor of myocardial infarc-
tion in subjects with BMI < 20 kg/m2, subjects with recommended
weight (BMI 20e25 kg/m2), as well as in overweight and obese
subjects (BMI > 25 kg/m2).15 Thus in further studies of the role of
adipokines and inﬂammation in the development of metabolic
disorders it will be of interest to investigate if fat mass estimated by
anthropometric measures can predict levels of inﬂammatory
markers not only in overweight, but also in lean subjects. Our
primary study aim was therefore to determine if any of the
frequently used anthropometric measures of fat mass (BMI, waist
circumference, waist-to-hip ratio, waist-to-height ratio and triceps
skinfold) were associated with BIA-measured fat mass. Further-
more we wanted to investigate the relationship between the
anthropometric measure with the strongest correlation with BIA,
and adipokines, inﬂammatory markers, markers of insulin resis-
tance and lipids among healthy subjects in different BMI categories.
2. Materials and methods
2.1. Subjects
The study population included 47 overweight and 40 lean
healthy adult volunteers (M:59/F:28). The overweight group con-
sisted of subjects available for baseline analysis in a contemporary
intervention trial performed in 2009. They were approached
through mass media and selected in accordance with the following
inclusion criteria: waist circumference >94 cm (men), >80 cm
(women), and BMI 26e40 kg/m2. Exclusion criteria were type 2
diabetes, kidney, liver, gall bladder, coronary, endocrine or rheu-
matoid disease, any malignancy the last 5 years, hypertension
(160/100 mmHg), pregnancy and lactation. Regular use of anti-
inﬂammatory, lipid lowering and antihypertensive medication was
not permitted. In 2010, a reference group of lean subjects was
recruited in the same way as the overweight subjects. Inclusion
criteriawere:waist circumference94 cm (men),80 cm (women),
BMI 17e25 kg/m2 and age 18e70 years. Exclusion criteria were the
same as for the overweight group. The study groups were matched
on age and sex. All subjects were instructed to refrain fromvigorous
physical activity and alcohol the daybefore the study visit. The study
protocol complied with the principles laid down in the Declaration
of Helsinki, and approved by the Regional Committee for Medical
andHealth Research Ethics.Written informed consentwas obtained
from all participants.
2.2. Laboratory methods
Venous blood samples were collected after an overnight fast
(12 h), between 8.00 and 10.00 a.m. Serum was obtained from
silica gel tubes (Becton Dickinson vacutainer, Plymouth, Great
Britain) and kept on ice, centrifuged (1500 g for 12 min), aliquoted
and stored at80 C until further analyses (inﬂammatorymarkers),
or kept in room temperature (for standard clinical chemistry) for at
least 30 min, until centrifugation at 1500 g for 12 min andPlease cite this article in press as: Wesseltoft-Rao N, et al., Measureme
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tained from EDTA tubes (Becton Dickinson), kept on ice and
centrifuged (2000 g, 4 C, 10 min) within 15 min. Plasma samples
were aliquoted and stored at 80 C until further analysis.
Serum leptin, serum adiponectin, serum resistin, plasma IL-6,
and plasma insulin-like growth factor-1 (IGF-1) levels were
measured by enzyme immunoassays from R&D Systems (Minne-
apolis, USA) according the manufacturer’s instructions. All analyses
were performed in duplicates. The coefﬁcients of variation for
intra-assay and inter-assay variability were <5% and <10%,
respectively, for all analyses. Standard blood chemistry and lipid
parameters were measured in serum or in EDTA plasma at Fürst
Medical Laboratory using routine methods (Oslo, Norway).
2.3. Assessment of fat mass
Subjects wore light clothing and no shoes. Two trained persons
performed all measurements, which were performed once, except
for triceps skinfold (TSF), which was measured three times. Height
wasmeasured by awall-mounted stadiometer to the nearest 0.1 cm.
Weight was measured by a Tanita scale (BC-418 MA, Tanita Corp.,
Tokyo, Japan) to the nearest 0.1 kg. A correction factor of 1 kg was
used to adjust for the weight of light clothing before BMI was
calculated. Waist- and hip circumferences were measured by
a standard, non-stretch tape to the nearest 0.1 cmwhile standing in
a relaxedpositionwithnormal respiration.Waist circumferencewas
measured at a point midway between the iliac crest and the lower
rib margin. Hip circumference was measured as the maximum
circumference of the posterior buttocks and the anterior symphysis.
The waist-hip ratio was calculated as waist circumference/hip
circumference and the waist-height ratio was calculated as waist
circumference/height. TSF was measured by using a Harpenden
Caliper and a standard, non-stretch tape on the non-dominant arm.
The midpoint of the arm was measured, with the measuring tape
between the shoulder (acromion) and the elbow (olecranon) while
the person was bending the arm 90. TSF and the mid-upper-arm
circumference (MUAC) were measured at this midpoint. The mid-
upper-arm muscle circumference (MUAMC) was calculated with
the equation MUAC- (p  (TSF/10)) ¼MUAMC (cm).2
Body composition was estimated using the single frequency
bioimpedance analyzer Tanita scale, operating at 50 kHz, with
eight-point contact electrodes.16 The electrode arrangement in the
system allows separate measurements for each arm and leg, the
trunk, and whole body. Fat mass (% and kg) were calculated from
the measured resistance values, height, body weight, sex, age, and
standard body type (deﬁned in the producer’s manual as less than
ten hour of exercise per week). Measurements were performed
with the subjects standing barefoot on the platform with arms
slightly apart from the body.
2.4. Statistical analysis
Normality distribution was assessed by looking at the QQ-plots
and the distribution of the histograms of the variables. Descriptive
statistics were used. Independent samples t-test was used for
comparison between groups. Univariate linear regression analyses
were applied to quantify the relationship between BIA- and
anthropometric measurements of body fat. Variables with P-values
<0.2 were included in the multivariate model. A stepwise model
reduction procedure was applied, where the F-ratio test was used.
In this test we step-by step eliminated the non-signiﬁcant variables
from the multivariate model. This was done to compare the results
with and without the non-signiﬁcant variables. The reduction
(elimination of non-signiﬁcant variables) was done until it was not
possible to reduce themodel any further. Although the groups werents of body fat is associated with markers of inﬂammation, insulin
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Table 1
Characteristics of the healthy overweight and lean subjects.a
Males
Pb
Females
Pc Pd Pe
Overweight, n ¼ 33 Lean, n ¼ 26 Overweight, n ¼ 14 Lean, n ¼ 14
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
Age (years) 52 (8.5) 53 (5.8) NSf 46 (11) 48 (9) NS NS NS
Height (cm) 180.5 (6.2) 182.7 (7.3) NS 169.0 (6.4) 170.5 (5.1) NS <0.001 <0.001
Weight (kg) 100.5 (11.7) 78.9 (8.3) <0.001 87.7 (11.8) 63.4 (8.4) <0.001 0.001 <0.001
BMI (kg/m2) 31 (3) 24 (1.3) <0.001 31 (3.1) 22 (2.3) <0.001 NS 0.013
Triglycerides (mmol/l) 1.6 (0.7) 1.1 (1.0) 0.027 1.2 (0.3) 0.6 (0.2) <0.001 0.040 0.056
Total cholesterol (mmol/l) 5.5 (0.8) 5.5 (1.0) NS 5.2 (0.8) 5.1 (0.9) NS NS NS
HDL-cholesterol (mmol/l) 1.2 (0.2) 1.6 (0.5) 0.001 1.4 (0.3) 1.9 (0.5) 0.004 0.004 0.052
LDL-cholesterol (mmol/l) 3.5 (0.8) 3.2 (0.8) NS 3.5 (0.6) 2.6 (0.7) 0.001 NS 0.021
Glucose (mmol/l) 6.2 (2.4) 5.2 (0.5) 0.033 5.4 (0.4) 5.1 (0.5) NS NS NS
Insulin (pmol/l) 72.3 (29.9) 45.5 (29.8) 0.001 77.9 (32.5) 36.4 (14.3) <0.001 NS NS
HOMAg 2.9 (1.7) 1.5 (1.0) <0.001 2.7 (1.1) 1.2 (0.6) <0.001 NS NS
C-peptide (pmol/l) 933 (239) 455 (167) <0.001 988 (270) 394 (123) <0.001 NS NS
HbA1c (%) 5.8 (1.2) 5.4h (0.2) 0.043 5.5 (0.3) 5.2 (0.4) 0.041 NS NS
a Compared to lean subjects, overweight subjects had higher (P < 0.05) levels of all variables except age, height and total cholesterol.
b Overweight males versus lean males.
c Overweight females versus lean females.
d Overweight males versus overweight females.
e Lean males versus lean females.
f NS ¼ non-signiﬁcant.
g Homeostasis Model Assessment ¼ fasting plasma glucose (mmol/l)  fasting insulin (mU/l)/22.5. Conversion factor for insulin units:mU/l ¼ pmol/l/6.945.
h n ¼ 25.
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any mistakes done in the matching procedure. In order to analyze
insulin resistance markers, lipids and inﬂammatory markers
concentration with respect to body fat, hip circumference, BIA
measures of fat percent and BMI were divided into tertiles and
analyzed with ANOVA. Sample size calculations were not per-
formed because of the descriptive design. Statistical signiﬁcance
was set as P< 0.05. The PASW18was used for all statistical analyses
(SPSS Inc., Chicago, Il).
3. Results
3.1. Subjects
Forty-seven (33men and14women) overweight (BMI 25e40 kg/
m2)whereof 25were obese (BMI> 30 kg/m2), and 40 lean (BMI 20e
25 kg/m2) subjects (26 men and 14 women) were included. The
overweight group had an age range from37 to 68 years, and the lean
from 36 to 65 years (Table 1). The data was normally distributed.
3.2. Insulin resistance markers and lipids
Overweight subjects had higher (P < 0.05) levels of all insulin
resistance markers (insulin, Homeostasis Model AssessmentTable 2
Concentrations of inﬂammatory markers and adipokines in healthy overweight and lean
Males
Pb
Overweight, n ¼ 33 Lean, n ¼ 26
Mean (s.d.) Mean (s.d.)
IL-6 (pg/ml) 1.4 (0.6) 1.0 (0.9) 0.071
Adiponectin (mg/ml) 2.7 (1.2) 3.6 (1.7) 0.016
Leptin (ng/ml) 11.7 (9.6) 3.2 (1.7) <0.001
Resistin (ng/ml) 10.2 (2.8) 8.4 (2.9) 0.015
IGF-1 (ng/ml) 126.1 (32.8) 125.0 (40.5) NS
CRP (mg/l) 1.8 (1.1) 1.0 (0.8) 0.002
a Compared to lean subjects, overweight subjects had higher (P < 0.05) levels of all va
b Overweight males versus lean males.
c Overweight females versus lean females.
d Overweight males versus overweight females.
e Lean males versus lean females.
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was elevated (P¼ 0.03) in overweightmen relative to the lean ones,
but this was not found among the women (Table 1).
No signiﬁcant differences in the plasma concentration of total
cholesterol were found between the overweight and lean subjects,
but the LDL-cholesterol and triglyceride levels were higher
(P < 0.05) whereas the HDL-cholesterol level was lower (P < 0.05)
in the overweight relative to the lean subjects (Table 1).
3.3. Inﬂammatory markers and adipokines
The overweight subjects had higher (P < 0.05) levels of CRP and
IL-6 than their lean counterparts. Overweight subjects also had
elevated (P< 0.05) levels of the leptin and resistin, compared to the
lean subjects, while the level of adiponectin was lower (P < 0.05).
Overweight women had higher levels of CRP than overweight men
(P ¼ 0.05) (Table 2) and women in both groups had higher
(P < 0.05) levels of leptin and adiponectin than men (Table 2).
3.4. Body composition in overweight and lean subjects
All body composition measures were signiﬁcantly elevated in
overweight compared with lean subjects. Both overweight and lean
women had higher TSF (P < 0.001), whole body fat (%) (P < 0.01)subjects.a
Females
Pc Pd Pe
Overweight, n ¼ 14 Lean, n ¼ 14
Mean (s.d.) Mean (s.d.)
1.8 (1.9) 0.9 (0.5) 0.069 NS NS
3.9 (1.8) 5.9 (2.2) 0.016 0.008 0.001
34.4 (9.5) 7.8 (3.9) <0.001 <0.001 <0.001
11.7 (3.3) 7.8 (3.4) 0.005 NS NS
117.7 (29.5) 123.6 (22.8) NS NS NS
2.6 (1.7) 0.7 (0.8) <0.001 0.048 NS
riables except IGF-1.
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Table 3
Body composition of the healthy overweight and lean subjects.a
Males
Pb
Females
Pc Pd Pe
Overweight, n ¼ 33 Lean, n ¼ 26 Overweight, n ¼ 14 Lean, n ¼ 14
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
Hip circumference (cm) 109.0 (7.0) 97.3 (4.7) <0.001 113.0 (7.5) 97.0 (5.3) <0.001 NS NS
Waist (cm) 108.2 (8.4) 85.7 (5.8) <0.001 99.5 (6.7) 74.0 (4.3) <0.001 <0.001 <0.001
Waist-hip ratio 1.0 (0.06) 0.9 (0.05) <0.001 0.9 (0.08) 0.8 (0.03) <0.001 <0.001 <0.001
Waist-height ratio 0.6 (0.07) 0.4 (0.03) <0.001 0.5 (0.06) 0.4 (0.04) <0.001 <0.001 NS
Triceps skinfold (mm) 21.1 (9.2) 9.6 (2.8) <0.001 32.7 (5.4) 17.0 (6.1) <0.001 <0.001 <0.001
Mid-upper-arm circumference (cm) 34.8 (2.5) 29.2 (2.0) <0.001 33.8 (2.9) 28.3 (6.3) 0.007 NS NS
Mid-upper-arm muscle circumference (cm) 28.2 (3.3) 26.2 (2.1) 0.007 23.5 (2.5) 23.0 (6.9) NS <0.001 0.009
Whole body fat (%) 29.0 (5.6) 18.3 (3.9) <0.001 42.7 (2.2) 28.4 (5.4) <0.001 <0.001 <0.001
Whole body fat mass (kg) 29.4 (8.0) 14.6 (3.8) <0.001 37.6 (6.6) 18.3 (5.2) <0.001 0.002 0.016
Total fat free mass (kg) 71.1 (7.5) 64.3 (6.3) 0.001 50.1 (5.7) 45.1 (4.9) 0.020 <0.001 <0.001
Trunk fat (%) 31.4 (5.6) 19.8 (4.9) <0.001 40.8 (2.4) 26.3 (7.8) <0.001 <0.001 0.003
Trunk fat mass (kg) 18.0 (4.5) 9.1 (2.7) <0.001 19.4 (3.2) 9.4 (3.6) <0.001 NS NS
Trunk fat free mass (kg) 38.7 (3.8) 36.1 (3.5) 0.010 28.0 (3.0) 25.6 (3.0) 0.040 <0.001 <0.001
a Compared to lean subjects, overweight subjects had higher (P < 0.05) levels of all variables.
b Overweight males versus lean males.
c Overweight females versus lean females.
d Overweight males versus overweight females.
e Lean males versus lean females.
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Males had higher levels for all other measurements than females
except for hip circumference, mid-upper-arm circumference and
trunk fat mass.3.5. Prediction of fat mass
To quantify the relationship between anthropometric estimates
of fat mass and body fat measured with BIAwe performed multiple
linear regression analyses (Table 4). Hip circumference had the
highest standardized coefﬁcient and explainedmost of the variation
inwhole body and trunk fatmass (% and kg) in both overweight and
lean subjects. Waist-to-hip ratio demonstrated the second highestTable 4
Predictors of fat mass and fat percentage derived from multiple regression analyses
in overweight and Lean subjects.a
Variables Predictors
Overweight, n ¼ 47
P
Lean, n ¼ 40
PBb 95% CI B 95% CI
Fat %
Whole body TSFc (mm) 0.32 0.0e0.6 0.03
HCd (cm) 0.51 0.3e0.7 0.00 0.41 0.2e0.7 0.00
WHRe 20.92 2.3e39.5 0.03
Trunk TSF (mm) 0.51 0.1e0.9 0.02
HC (cm) 0.51 0.3e0.7 0.00 0.52 0.2e0.9 0.01
WHR 21.92 3.1e40.8 0.02
Fat mass, kg
Whole body WHtRf (cm) 79.61 55.7e103.6 0.00
TSF (mm) 0.32 0.1e0.5 0.02
HC (cm) 1.01 0.9e1.2 0.00
WHR 41.52 24.0e58.0 0.00
Trunk TSF (mm) 0.22 0.1e0.4 0.01
HC (cm) 0.41 0.3e0.5 0.00 0.41 0.2e0.5 0.00
Waistg (cm) 0.22 0.1e0.3 0.00
a Adjusted for age and sex.
b B: regression coefﬁcient (kg). The predictor with the highest standardized
coefﬁcient that explains most of the variation of the dependent variable is ranked 1,
the second highest 2.
c TSF ¼ triceps skinfold.
d HC ¼ hip circumference.
e WHR ¼ waist-to-hip ratio.
f WHtR ¼ waist-to-height ratio.
g Waist ¼ waist circumference.
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trunk fat (%) in overweight subjects. In lean subjects, TSF had the
second highest standardized coefﬁcient for all BIA measures of fat
mass. In summary, the results showed that measurements of hip
circumferencewerehighlyassociatedwithwholebodyand trunk fat
mass expressed in kg and percentage, in both lean and overweight
subjects. The results also indicated that an increase in hip circum-
ference with one cm in both overweight and lean subjects corre-
sponded to an increase in the trunk body fat mass with 360 g.3.6. Relationship between insulin resistance markers, lipids and
inﬂammatory markers, and body fat
Becausemeasurements ofhip circumferencewere closely related
toBIA-derived fatmass inboth leanandoverweight subjects, tertiles
ofhip circumferenceandwholebody fat (%)wereused toanalyze the
relation between fat mass and markers of insulin resistance, lipids
and inﬂammatory markers (Tables 5 and 6). We also divided BMI
into tertiles and performed the same analysis (Table 7).
In overweight subjects, IL-6 was reduced across tertiles of hip
circumference (Table 5). Levels of adiponectin and leptin increased,
while resistin decreased. There was also an elevation of IGF-1 and
CRP concentrations. Levels of HOMA (P < 0.05) and C-peptide
(P < 0.05) increased and an elevation of triglycerides was seen,
while HDL-cholesterol remained stable (Table 5). The same trends
were found regarding tertiles of BMI in the overweight subjects,
except for a signiﬁcant decrease of resistin (P < 0.05) and elevated
C-peptide (P < 0.01) levels (Table 7). Across tertiles of whole body
fat (%) (Table 6), there were also increasing trends in adiponectin
(P < 0.01) and leptin (P < 0.01), IGF-1, CRP, HOMA, and C-peptide.
Concentrations of IL-6 and resistin (P < 0.05) increased across
tertiles, and triglyceride concentrations decreased.
Regarding the relation to tertiles of hip circumference in lean
subjects (Table 5), IL-6 and adiponectin were reduced, and leptin
(P < 0.01) and resistin values were increased. Levels of IGF-1, CRP,
HOMA, C-peptide and triglycerides were increased, while HDL-
cholesterol was reduced. Similar trends were found for tertiles of
BMI in the lean subjects, except for resistin which was decreased
across tertiles, and CRP (P < 0.05), which was signiﬁcantly
increased (Table 7). Like for the tertiles of hip circumference and
BMI, leptin (P < 0.01), IGF-1, CRP, HOMA and C-peptide, increased
across tertiles of fat (%) (Table 6). IL-6 values however were stablents of body fat is associated with markers of inﬂammation, insulin
lthy subjects, e-SPEN Journal (2012), http://dx.doi.org/10.1016/
Table 5
Levels of plasma markers by tertiles of hip circumference.
Overweight tertiles of hip circumference (cm) Normal weight tertiles of hip circumference (cm)
106.8, n ¼ 16, Fa:4 106.81e113.3, n ¼ 16, Fa:5 >113.3, n ¼ 15, Fa:5 94.5, n ¼ 13, Fa:6 94.51e99.99, n ¼ 12, Fa:3 >99.99, n ¼ 15, Fa:5
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
IL-6 (pg/ml) 1.7 (1.8) 1.3 (0.7) 1.4 (0.4) 1.0 (0.6) 0.9 (0.9) 0.9 (0.9)
Adiponectin (mg/ml) 2.9 (1.0) 2.8 (1.2) 3.6 (2.0) 5.4 (2.4) 3.7 (2.0) 4.1 (1.9)
Leptin (ng/ml) 14.0 (11.7) 16.4 (13.7) 25.5 (15.1) 3.7 (3.2) 4.2 (3.3) 6.1 (3.5)c
Resistin (ng/ml) 10.2 (1.9) 11.9 (2.9) 9.9 (3.8) 7.3 (2.5) 9.1 (3.2) 8.1 (3.3)
IGF-1 (ng/ml) 122.6 (31.8) 122.2 (24.3) 126.2 (39.9) 119.5 (31.4) 113.0 (34.0) 138.1 (36.2)
CRP (mg/ml) 2.1 (1.5) 1.7 (1.3) 2.3 (1.2) 0.7 (0.5) 0.8 (0.6) 1.1 (1.1)
HOMA 18.5 (11.8) 15.8 (5.2) 25.1 (12.2)b 8.0 (6.4) 10.4 (8.7) 11.5 (3.8)
C-peptide (pmol/l) 881.2 (248.2) 882.1 (199.5) 1094.1 (242.7)b 399.2 (135.4) 410.5 (182.8) 482.5 (142.6)
Triglycerides (mmol/l) 1.45 (0.44) 1.35 (0.68) 1.58 (0.71) 0.64 (0.28) 1.14 (1.39) 0.95 (0.44)
HDL-cholesterol (mmol/l) 1.24 (0.23) 1.24 (0.36) 1.23 (0.31) 1.92 (0.56) 1.66 (0.52) 1.47 (0.37)
a F ¼ number of females.
b Differences across the three tertile groups P < 0.05.
c Differences across the three tertile groups P < 0.01.
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cholesterol increased across tertiles of fat (%).
4. Discussion
Obesity increases the risk of chronic diseases and the total
amount of fat and its distribution are possibly the most important
determinants of these disorders.3 Hip circumference was found to
be the anthropometric measure that best reﬂected whole body fat
(%) and trunk fat (%) as measured with BIA, in both lean and
overweight subjects. Interestingly we found a tendency toward
higher concentrations of leptin, CRP, and C-peptide, as well as
adiponectin and HDL, with higher fat (%), also in subjects with
a BMI within the recommended range.
In this study we related frequently used anthropometric
measures (BMI, TSF, waist and hip circumference, waist-to-height,
waist-to-hip ratio) to fat mass assessed by BIA. Several studies
have validated BIA by using DXA.15 In comparison with DXA, BIA
tends to overestimate fat mass (% and kg) in lean individuals and
underestimate fat mass in obese.17 Despite these limitations BIA is
considered an acceptable tool for predicting body fat in healthy
populations.11 A recent study also demonstrated that BIA correlated
signiﬁcantly with anthropometric measurements.18 This is in
accordance with our study as we found that TSF correlated signif-
icantly with BIA measures of fat (% and kg) in lean subjects and
waist circumference correlated with BIA measures of fat in over-
weight subjects. Hip circumference reﬂected BIA-measured fat in
both groups.Table 6
Levels of inﬂammatory markers and adipokines by tertiles of whole body fat (%).
Overweight tertiles of fat (%)
26.8, n ¼ 16, Fa:0 26.81e34.6, n ¼ 16, Fa:0 >34.6, n ¼
Mean (SD) Mean (SD) Mean (SD
IL-6 (pg/ml) 1.1 (0.4) 1.6 (0.6) 1.8 (1.8
Adiponectin (mg/ml) 2.5 (0.8) 2.6 (0.6) 4.2 (2.0
Leptin (ng/ml) 7.0 (3.1) 13.9 (6.8) 35.6 (10.
Resistin (ng/ml) 11.4 (2.7) 9.2 (2.4) 11.5 (3.3
IGF-1 (ng/ml) 130.6 (31.0) 117.2 (29.9) 123.0 (35.
CRP (mg/ml) 1.5 (0.88) 2.1 (1.2) 2.6 (1.7
HOMA 16.5 (13.9) 24.5 (13.9) 27.9 (7.9
C-peptide (pmol/l) 853.4 (215.6) 1023.8 (241.0) 972.8 (266
Triglycerides (mmol/l) 1.55 (0.76) 1.62 (0.60) 1.17 (0.3
HDL-cholesterol (mmol/l) 1.14 (0.24) 1.16 (0.25) 1.42 (0.3
a F ¼ number of females.
b Differences across the three tertile groups P < 0.05.
c Differences across the three tertile groups P < 0.01.
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j.clnme.2012.10.002In obesity the fat tissue produces adipokines19 and cytokines,
which may result in chronic inﬂammation.20 It has been shown that
systemic inﬂammation is higher in obese than in normal weight
persons.21 Leptin is preferentially secreted by subcutaneous adipose
tissue,22 and the concentration is dependent on adipocyte size23 as
well as energy balance.21 In our study we found a strong association
between hip circumference andwhole body fat (%), and leptin levels.
The same association was also found with BMI. Normally, leptin
levels are higher in obese individuals as demonstrated here. Inter-
estingly we observed that leptin levels increased with increasing fat
(%) also in the lean group. One could argue that this could be an effect
of food intake or macrophage inﬁltration in adipose tissue due to
weight gain, which is known to produce higher leptin levels.
However, in both study groups the blood levels were measured
during fasting and all subjects reported stableweight for at least two
months prior to inclusion. Few studies have shown the same trend
with leptin levels in lean people, but a positive association between
fat mass accumulation, oxidative stress indices and leptin levels has
been observed,7 suggesting that fat mass-induced oxidative stress
may cause a dysregulation of adipokines, also in lean subjects.
A positive relationship between BMI, waist circumference and
CRP has been documented.24 This is in accordancewith our study as
we found that CRP increased with increasing BMI and interestingly,
this positive relationship was signiﬁcant in lean subjects. We also
found an association between hip circumference and whole body
fat (%) and CRP, although not signiﬁcant. These results conﬁrm the
ﬁndings by Arner et al.25 of an association between inﬂammation
and fat mass in lean individuals. There is also evidence that IL-6,Normal weight tertiles of fat (%)
15, Fa:14 18.6, n ¼ 14, Fa:0 18.61e24.8, n ¼ 13, Fa:3 >24.8, n ¼ 13, Fa:11
) Mean (SD) Mean (SD) Mean (SD)
) 0.8 (0.5) 1.3 (1.3) 0.8 (0.3)
)c 3.3 (1.9) 4.9 (2.2) 5.2 (2.0)b
3)c 2.4 (1.5) 4.0 (2.0) 8.1 (3.6)c
)b 8.4 (3.5) 8.6 (2.2) 7.5 (3.5)
1) 124.7 (42.5) 120.4 (33.5) 128.4 (29.3)
) 0.9 (0.5) 0.8 (0.8) 1.0 (1.2)
) 7.9 (3.6) 12.6 (9.5) 8.6 (3.8)
.5) 393.8 (130.0) 514.7 (182.4) 396.1 (124.2)
3) 0.80 (0.31) 1.27 (1.34) 0.65 (0.27)
1)c 1.72 (0.54) 1.52 (0.56) 1.77 (0.51)
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Table 7
Levels of inﬂammatory markers and adipokines by tertiles of body mass index.
Overweight tertiles of BMI (kg/m2) Normal weight tertiles of BMI (kg/m2)
29.4, n ¼ 16, Fa:5 29.41e31.8, n ¼ 16, Fa:5 >31.8, n ¼ 15, Fa:4 22.4, n ¼ 14, Fa:9 22.41e24.1, n ¼ 14, Fa:2 >24.1, n ¼ 12, Fa:3
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
IL-6 (pg/ml) 1.8 (1.9) 1.4 (0.5) 1.4 (0.3) 1.0 (0.6) 1.0 (0.8) 0.9 (1.0)
Adiponectin (mg/ml) 3.0 (1.4) 2.9 (1.4) 3.3 (1.7) 5.4 (2.3) 4.0 (1.9) 3.8 (2.0)
Leptin (ng/ml) 13.9 (12.3) 18.8 (14.0) 23.0 (15.5) 4.8 (3.4) 4.4 (3.5) 5.2 (3.7)
Resistin (ng/ml) 10.3 (1.7) 12.4 (3.7) 9.3 (2.5)b 8.4 (3.0) 8.0 (2.2) 8.2 (3.1)
IGF-1 (ng/ml) 118.1 (31.3) 128.0 (23.0) 124.9 (40.6) 117.4 (30.0) 138.0 (36.7) 124.5 (35.0)
CRP (mg/ml) 1.7 (0.7) 1.8 (1.3) 2.7 (1.7) 0.5 (0.4) 0.8 (0.5) 1.4 (1.2)b
HOMA 13.1 (5.8) 23.2 (13.2) 23.0 (9.9)b 7.7 (6.0) 9.3 (3.2) 12.3 (8.8)
C-peptide (pmol/l) 791.1 (197.8) 977.3 (208.6) 1088.7 (248.2)c 377.0 (140.3) 424.4 (113.8) 511.1 (187.7)
Triglycerides (mmol/l) 1.33 (0.52) 1.42 (0.64) 1.63 (0.68) 0.63 (0.31) 0.81 (0.25) 1.35 (1.38)
HDL-cholesterol (mmol/l) 1.28 (0.33) 1.22 (0.30) 1.20 (0.26) 1.91 (0.54) 1.68 (0.43) 1.39 (0.44)b
a F ¼ number of females.
b Differences across the three tertile groups P < 0.05.
c Differences across the three tertile groups P < 0.01.
N. Wesseltoft-Rao et al. / e-SPEN Journal xxx (2012) e1ee7e6a key determinant of CRP production in hepatocytes, is secreted in
proportion to the expansion of fat mass, particularly in the
abdominal region.26 We did, however, not detect stronger associ-
ations with CRP and trunk fat mass than with other fat measures.
Other adipose tissue depots in ectopic sites (liver, heart, skeletal
muscle) may contribute to the production of inﬂammatory medi-
ators in the absence of obesity.27
Chronic inﬂammation promotes insulin resistance and cardio-
vascular disease.5 Our results show an increase in HOMA and C-
peptide as hip circumference and BMI increased, and an elevation of
these markers from the lowest to the highest tertile of whole body
fat (%) in both groups. Low level of HDL-cholesterol is an important
risk factor for cardiovascular disease.28 One would expect a reduc-
tion in HDL-cholesterol as fat mass expands. This was found in our
studywith increasing hip circumference in lean individuals andwith
increasing BMI in both groups. In the overweight however, we found
stable levels of HDL-cholesterol as hip circumference increased, and
elevated levels of HDL-cholesterol from the lowest to highest tertile
of whole body fat (%). Elevated HDL-cholesterol levels were followed
by an inverse reduction of triglyceride levels. Studies have described
a subset of obese individuals, termed metabolically healthy, which
appear to be resistant to the development of metabolic distur-
bances.29 They have high fat mass and high BMI and high HDL, but
low triglycerides and visceral fat and normal insulin sensitivity. In
our study a subgroup of the overweight people, namely those with
BMI > 30 kg/m2, but no elevated HOMA, triglyceride- or LDL levels,
had the highest levels of whole body fat (%). It should be noted that
all the overweight women in our study were in the highest tertile of
fat (%). This may also explain our ﬁndings regarding adiponectin: In
the overweight group we found elevated levels of adiponectin in the
highest tertiles of hip circumference, whole body fat (%) and BMI.
Earlier studies show a decrease30 in adiponectin levels as fat mass
accumulates and an elevation with weight loss.27
The major strength of our study is that we examined a broad
range of anthropometric measures. Our study has some limitations
since we used indirect measurements as indicators of total and
central fatness. It is therefore difﬁcult to determine exactly the
relative contributions of subcutaneous versus visceral fat. The
number of subjects was relatively low and the results should be
conﬁrmed in a larger population. The age and gender heterogeneity
is also a limitation, although the variable was adjusted for.
In conclusion, we have showed that measurements of hip
circumference to assess total body and trunk fat (%) may represent
a valid substitute to BIAmeasurements in both lean and overweight
subjects. Thus this is a highly feasible method outside the hospital
setting in order to identify people at risk of increased inﬂammation
and insulin resistance.Please cite this article in press as: Wesseltoft-Rao N, et al., Measureme
resistance and lipid levels in both overweight and in lean, hea
j.clnme.2012.10.002Our results may also suggest that fat (%) is associated with
elevation of risk factors for lifestyle related disorders among lean
persons. Although the choice of fat measure may impact on the
magnitude of these associations, adherence to a healthy lifestyle is
also important for people within the recommended range of BMI.
The relationship between markers of inﬂammation, insulin resis-
tance and lipids in lean as well as overweight subjects should be
studied further in order to understand the role of fat mass in
healthy subjects with different BMI. Such knowledge may be of
considerable interest for early identiﬁcation of subjects at risk of
type 2 diabetes and cardiovascular disease.
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